Oscar Health, Inc. (OSCR) P/E Ratio History
Historical price-to-earnings valuation from 2025 to 2025
Loading P/E history...
OSCR Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 6, 2026, Oscar Health, Inc. (OSCR) trades at a price-to-earnings ratio of -11.7x, with a stock price of $19.84 and trailing twelve-month earnings per share of $-0.12.
The current P/E is 123% below its 5-year average of 50.4x. Over the past five years, OSCR's P/E has ranged from a low of 50.4x to a high of 50.4x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, OSCR trades at a 153% discount to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 178.0x.
Relative to the broader market, OSCR trades at a notable discount to the S&P 500 median P/E of 25.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our OSCR DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
OSCR P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $34B | 8.1Lowest | 0.29Best | +4% | |
| $333B | 27.8 | - | -15% | |
| $111B | 62.5 | - | -62% | |
| $74B | 12.7 | - | +83%Best | |
| $81B | 14.9 | 2.16 | -2% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
OSCR Historical P/E Data (2025–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $13.11 | $0.26 | 50.4x | +0% |
Average P/E for displayed period: 50.4x
See OSCR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs OSCR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare OSCR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonOSCR — Frequently Asked Questions
Quick answers to the most common questions about buying OSCR stock.
Is OSCR stock overvalued or undervalued?
OSCR trades at -11.7x P/E, below its 5-year average of 50.4x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does OSCR's valuation compare to peers?
Oscar Health, Inc. P/E of -11.7x compares to sector median of 22.1x. The discount suggests lower growth expectations or higher risk.
What is OSCR's PEG ratio?
OSCR PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2025-2025.